Related Experiment Video
Updated: Sep 9, 2025

Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
A Rare Case of Rapidly Progressing Merkel Cell Carcinoma
David Sau Ting Jain1,2, Omer Riyadh3,2, Kayla Tran1,2
1Medicine, O'Connor Hospital, San Jose, USA.
None:
Merkel cell carcinoma (MCC) is a highly aggressive neuroendocrine tumor, known for its rapid progression and poor prognosis. It most commonly affects elderly and immunocompromised individuals, with variable clinical presentations that can make diagnosis challenging. MCC is often mistaken for other skin malignancies, such as basal or squamous cell carcinoma, or even benign skin lesions. Early diagnosis is critical to initiate appropriate treatment, typically involving surgery, radiation, and immunotherapy. This report describes a 66-year-old man diagnosed with MCC with regional lymph node involvement. Immunotherapy was started promptly; however, within a year, the disease progressed to the mediastinum, involving the esophagus and trachea, an uncommon site of metastasis. The patient ultimately died in the ICU from respiratory failure. This case highlights the aggressive behavior of MCC and underscores the importance of vigilant follow-up, even after early diagnosis. Once metastasis to the lymph nodes occurs, MCC becomes particularly challenging to manage, especially when it follows an atypical metastatic pattern.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

